Gyeongnam Pharmaceutical Reports Operating Profit of 2.1 Billion KRW Last Year... Returns to Profitability
[Asia Economy Reporter Minji Lee] Kyungnam Pharmaceutical announced on the 19th that it recorded an operating profit of 2.1 billion KRW last year, turning to a surplus. Sales increased by 58% to 70.9 billion KRW. Net loss continued at 5.6 billion KRW following last year’s deficit.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- [Weather] Nationwide Rain Brings Relief from Heat... Up to 80mm or More Expected
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
The company explained, “Sales growth of major products such as Lemona and Jahasaengryeok, as well as increased sales of new products,” and added, “Derivative valuation losses were reflected in financial expenses, resulting in increased loss from continuing operations before income tax and net loss for the period.”
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
